相关产品推荐更多 >

EZElisa™人血小板衍生生长因子CC(PDGF-CC)ELISA试剂盒-EZElisa™ Human Platelet-derived Growth Factor CC (PDGF-CC) ELISA Kit
询价
EZElisa™黄嘌呤脱氢酶(XDH)试剂盒-EZElisa™ Xanthine Dehydrogenase (XDH) Kit
询价
EZElisa™兔高灵敏度白细胞介素6(IL 6)ELISA试剂盒-EZElisa™ Rabbit High Sensitive Interleukin 6 (IL6) ELISA Kit
询价
EZElisa™ Receptor I for the Fc Region of Immunoglobulin G(FcγR I)试剂盒-EZElisa™ Receptor I for the Fc Region of Immunoglobulin G (FcγR I) Kit
询价
EZElisa™ DNA聚合酶α亚基B(大鼠Pola2)ELISA试剂盒-EZElisa™ DNA polymerase alpha subunit B (Rat Pola2) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
运输过程中保存:2-8℃
- 保质期:
1年
- 英文名:
EZElisa™ Human Deleted In Malignant Brain Tumors 1 (DMBT1) ELISA Kit
- 库存:
100
- 供应商:
艾美捷科技
EZElisa™人类恶性脑肿瘤1(DMBT1)ELISA试剂盒,EZElisa™ Human Deleted In Malignant Brain Tumors 1 (DMBT1) ELISA Kit,类恶性脑肿瘤1(DMBT1)ELISA试剂盒, Deleted In Malignant Brain Tumors 1 (DMBT1) ELISA Kit
产品名称:EZElisa™人德尔塔样蛋白3(dLL3)ELISA试剂盒-EZElisa™ Human Deleted In Malignant Brain Tumors 1 (DMBT1) ELISA Kit
产品货号:A-QEK02971-96wells
产品规格:96wells

Enzyme Immunoassay for the estimation of Deleted In Malignant Brain Tumors 1 (DMBT1) in serum and plasma, tissue homogenates and other biological fluids.
种属:Human
检测方法:比色法
检测范围:0.156 - 10 ng/ml

该EZElisa™人类恶性脑肿瘤1(DMBT1)ELISA试剂盒ELISA的特点包括:即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证,符合金环标准质量ELISA的要求,这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物,样品可以是血清

运输过程中保存:2-8℃
点击:EZElisa™人德尔塔样蛋白3(dLL3)ELISA试剂盒-EZElisa™ Human Deleted In Malignant Brain Tumors 1 (DMBT1) ELISA Kit更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Human brain neoplasms comprise a highly heterogeneous and biologically diverse group of tumors, the most common and most malignant of which are those of neuroepithelial origin (1 ) Despite intensive research, little is still understood
Isolation and Culture of Human Brain Tumor Cells
and has not significantly improved over the past 20 years. It is a common belief in the neuro-oncology field that development of combination therapies for malignant brain tumors will be essential if improvement in survival is to occur (3 ,4 ). To test experimental single
Gene Transfer to Glial Tumors Using Herpes Simplex Virus
Glial tumors occur as intraaxial masses in the brain and are uniformly fatal due to lack of effective therapy. Resection combined with radiation and chemotherapy fails to eradicate malignant cells infiltrating into normal brain
技术资料暂无技术资料 索取技术资料




